CRISPR Therapeutics AG

Ownership Transactions Reported by 22 Insiders

Symbol
CRSP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Baarerstrasse 14, Zug, Switzerland

Insiders trading volume in the past year

CRISPR Therapeutics AG executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Simeon George Director $90M +$51.5M +134% Jul 16, 2025
Rodger Novak President, Director $35.8M Jun 30, 2021
Samarth Kulkarni Chief Executive Officer, Director $22.8M -$8.38M -26.9% Oct 16, 2025
Bradley J. Bolzon PhD Director $9.3M Jun 9, 2022
James R. Kasinger General Counsel and Secretary $5.55M -$992K -15.1% Oct 13, 2025
Tony W. Ho Executive VP, Head of R&D $3.27M Dec 3, 2021
Lawrence Otto Klein Cbo & Coo $1.67M Aug 16, 2022
Douglas A. Treco Director $1.25M +$1.14M +1000% Aug 6, 2025
Julianne Bruno Chief Operating Officer $727K -$147K -16.8% Mar 20, 2025
Raju Prasad Chief Financial Officer $691K -$248K -26.4% Oct 3, 2025
Brendan Smith Chief Financial Officer $317K Feb 18, 2023
John Greene Director $314K +$314K Jun 5, 2025
Phuong Khanh Morrow Chief Medical Officer $276K Oct 13, 2023
Naimish Patel Chief Medical Officer $218K -$141K -39.3% Oct 3, 2025
Briggs Morrison Director $196K Jun 5, 2025
Michael John Tomsicek Chief Financial Officer $118K Aug 6, 2021
Sandesh Mahatme Director Jun 5, 2025
Harold Edward Fleming Director Jun 5, 2025
Ali Behbahani Director Jun 5, 2025
Maria Fardis Director Jun 5, 2025
Christian Rommel Director Jun 5, 2025
Katherine A. High Director Jun 5, 2025

Recent Insider Transactions by Companies or Individuals for CRISPR Therapeutics AG

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.